MétaCan
Menu
Back to cohort
Record W4409229213 · doi:10.1016/j.jocn.2025.111230

Acyclovir dosing strategies in herpes encephalitis: A retrospective charts review

2025· article· en· W4409229213 on OpenAlexafffundabout
Asma Aboelezz, Maged Kharouba, Sherif Hanafy Mahmoud

Bibliographic record

VenueJournal of Clinical Neuroscience · 2025
Typearticle
Languageen
FieldMedicine
TopicHerpesvirus Infections and Treatments
Canadian institutionsUniversity of Alberta
FundersFaculty of Pharmacy and Pharmaceutical Sciences, University of AlbertaUniversity Hospital FoundationUniversity of Alberta
KeywordsMedicineDosingEncephalitisRetrospective cohort studyPediatricsIntensive care medicineVirologyPharmacologyInternal medicineVirus

Abstract

fetched live from OpenAlex

BACKGROUND: Herpes encephalitis is a life-threatening condition that causes severe inflammation of the brain, often leading to permanent neurological damage or death if not treated promptly. Acyclovir is the main antiviral treatment for herpes encephalitis. Early use is essential to lower the risk of severe brain damage and improve survival rates. The objectives of this study were to describe the dosing of acyclovir in patients with suspected encephalitis and to determine the potential association between acyclovir dosage regimen and its safety and effectiveness. METHODS: A retrospective single-center observational study of patients admitted to the University of Alberta Hospital who received acyclovir and were suspected of having or diagnosed with herpes encephalitis. Patient charts were reviewed. Patient demographics, history of comorbidities, concomitant nephrotoxic medications, hospitalization department, length of hospital stay, acyclovir dosing, viral encephalitis diagnosis and outcomes were collected. Effectiveness outcomes included full recovery, partial recovery and death. Safety outcomes included the development of acute kidney injury (AKI) while on acyclovir treatment. We analyzed predictors of the outcomes using regression modeling. RESULTS: A total of 237 patients were included in the study. Among the patients who received acyclovir for more than 2 days, 88 (57 %) patients received an adequate dose, 54 (35 %) patients received sub-therapeutic dosage regimen and 12 (8 %) patients received supra-therapeutic regimen. Older age was associated with less favorable outcomes (adjusted odds ratio (OR) 1.05, 95 % Confidence Interval (CI) 1.01-1.09, p = 0.02). Additionally, there was a trend suggesting that herpes simplex virus type 1 (HSV-1) resulted in the worst outcomes, with the highest percentage of unfavorable outcomes observed in the sub-therapeutic dosing group. In contrast, supra-therapeutic dose of acyclovir was significantly associated with AKI (adjusted OR 12.9, 95 %CI 3.14-53.07, p < 0.001). CONCLUSION: Our study suggests that administering acyclovir based on actual body weight for non-obese patients and adjusted body weight for obese patients may enhance outcomes by promoting recovery and preventing toxicity. Multicenter prospective studies are needed to confirm such association and to provide clear guidelines of the most appropriate dosing of acyclovir in herpes encephalitis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.221
Threshold uncertainty score0.345

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.467
Teacher spread0.406 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations9
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueJournal of Clinical NeuroscienceSame topicHerpesvirus Infections and TreatmentsFrench-language works237,207